Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
Catalyst Pharmaceuticals (Nasdaq: CPRX) has announced its participation in two major upcoming investor conferences. The company's President and CEO Richard J. Daly, along with other management team members, will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, at 2:00 PM ET, and at Citi's 2024 Global Healthcare Conference on Wednesday, December 4, 2024, at 1:00 PM ET. Both presentations will be available via webcast on the company's website under the Investors section, with replays accessible for at least 30 days.
Catalyst Pharmaceuticals (Nasdaq: CPRX) ha annunciato la sua partecipazione a due importanti conferenze per investitori in arrivo. Il Presidente e CEO dell'azienda, Richard J. Daly, insieme ad altri membri del team di gestione, presenterà alla Piper Sandler 36ª Conferenza Annuale sulla Salute martedì 3 dicembre 2024, alle 14:00 ET, e alla Conferenza Globale sulla Salute 2024 di Citi mercoledì 4 dicembre 2024, alle 13:00 ET. Entrambe le presentazioni saranno disponibili tramite webcast sul sito web dell'azienda nella sezione Investitori, con replay accessibili per almeno 30 giorni.
Catalyst Pharmaceuticals (Nasdaq: CPRX) ha anunciado su participación en dos importantes conferencias de inversores próximas. El Presidente y CEO de la compañía, Richard J. Daly, junto con otros miembros del equipo de gestión, presentará en la 36ª Conferencia Anual de Salud de Piper Sandler el martes 3 de diciembre de 2024, a las 2:00 PM ET, y en la Conferencia Global de Salud 2024 de Citi el miércoles 4 de diciembre de 2024, a la 1:00 PM ET. Ambas presentaciones estarán disponibles a través de un webcast en el sitio web de la empresa en la sección de Inversores, con repeticiones accesibles durante al menos 30 días.
Catalyst Pharmaceuticals (Nasdaq: CPRX)가 두 가지 주요 투자자 회의에 참가한다고 발표했습니다. 회사의 회장 겸 CEO인 Richard J. Daly와 다른 경영팀 구성원들은 2024년 12월 3일 화요일 오후 2시(ET)에 열리는 Piper Sandler 제36회 연례 헬스케어 컨퍼런스와 2024년 12월 4일 수요일 오후 1시(ET)에 열리는 Citi의 2024 글로벌 헬스케어 컨퍼런스에서 발표를 진행할 예정입니다. 두 발표 모두 회사 웹사이트의 투자자 섹션에서 웹캐스트를 통해 제공되며, 최소 30일 동안 재생할 수 있습니다.
Catalyst Pharmaceuticals (Nasdaq: CPRX) a annoncé sa participation à deux grandes conférences pour investisseurs à venir. Le Président et CEO de la société, Richard J. Daly, ainsi que d'autres membres de l'équipe de direction, présenteront à la 36e Conférence Annuelle sur la Santé de Piper Sandler le mardi 3 décembre 2024, à 14h00 ET, et à la Conférence Mondiale sur la Santé 2024 de Citi le mercredi 4 décembre 2024, à 13h00 ET. Les deux présentations seront disponibles via un webinaire sur le site de l'entreprise dans la section Investisseurs, avec des rediffusions accessibles pendant au moins 30 jours.
Catalyst Pharmaceuticals (Nasdaq: CPRX) hat seine Teilnahme an zwei wichtigen bevorstehenden Investorenkonferenzen bekannt gegeben. Der Präsident und CEO des Unternehmens, Richard J. Daly, wird zusammen mit anderen Mitgliedern des Managementteams am Dienstag, den 3. Dezember 2024, um 14:00 Uhr ET auf der 36. jährlichen Gesundheitskonferenz von Piper Sandler und am Mittwoch, den 4. Dezember 2024, um 13:00 Uhr ET auf der 2024 Global Healthcare Conference von Citi präsentieren. Beide Präsentationen werden über einen Webcast auf der Unternehmenswebsite im Bereich Investoren verfügbar sein, wobei Wiederholungen mindestens 30 Tage lang zugänglich sind.
- None.
- None.
CORAL GABLES, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst's management team, will participate in the upcoming investor conferences detailed below.
Piper Sandler 36th Annual Healthcare Conference
Date: Tuesday, December 3, 2024
Presentation: 2:00 PM ET
Webcast Link
Citi's 2024 Global Healthcare Conference
Date: Wednesday, December 4, 2024
Presentation: 1:00 PM ET
Webcast Link
The webcasts will be available under the Investors section on the Company's website, www.catalystpharma.com, and a replay will be available for at least 30 days.
About Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) is a biopharmaceutical company committed to improving the lives of patients with rare diseases. With a proven track record of bringing life-changing treatments to the market, we focus on in-licensing, commercializing, and developing innovative therapies. Guided by our deep commitment to patient care, we prioritize accessibility, ensuring patients receive the care they need through a comprehensive suite of support services designed to provide seamless access and ongoing assistance. Catalyst maintains a well-established U.S. presence while actively seeking to expand its global commercial footprint through strategic partnerships. Catalyst is headquartered in Coral Gables, FL., and was recognized on the Forbes 2024 list as one of America's most successful small-cap companies.
For more information, please visit Catalyst's website at www.catalystpharma.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause Catalyst's actual results in future periods to differ materially from forecasted results. A number of factors, including those factors described in Catalyst's Annual Report on Form 10-K for the fiscal year 2023 and its other filings with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect Catalyst. Copies of Catalyst's filings with the SEC are available from the SEC, may be found on Catalyst's website, or may be obtained upon request from Catalyst. Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.
Source: Catalyst Pharmaceuticals, Inc.
FAQ
When is Catalyst Pharmaceuticals (CPRX) presenting at the Piper Sandler Healthcare Conference 2024?
What time is Catalyst Pharmaceuticals (CPRX) presenting at Citi's 2024 Global Healthcare Conference?
Where can I watch Catalyst Pharmaceuticals' (CPRX) investor conference presentations?